Cite
APA Citation
Weekes, C., Lockhart, A., LoRusso, P., Murray, E., Park, E., Tagen, M., Singh, J., Sarkar, I., Mueller, L., Dokainish, H., Shapiro, G., & Burris, H. (2020). a Phase Ib Study to Evaluate the MEK Inhibitor Cobimetinib in Combination with the ERK1/2 Inhibitor GDC‐0994 in Patients with Advanced Solid Tumors. Oncologist, 25, 833–e1438. http://access.bl.uk/ark:/81055/vdc_100112032936.0x000038